Disc Medicine
IRON
50 hedge funds and large institutions have $33.7M invested in Disc Medicine in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 8 increasing their positions, 16 reducing their positions, and 19 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
52% more call options, than puts
Call options by funds: $126K | Put options by funds: $83K
0.2% less ownership
Funds ownership: 2.2% → 2% (-0.2%)
12% less funds holding
Funds holding: 57 → 50 (-7)
15% less capital invested
Capital invested by funds: $39.6M → $33.7M (-$5.86M)
32% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 19
50% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
+$432K |
| 2 |
Millennium Management
New York
|
+$333K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$333K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$222K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$204K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.6M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$1.49M |
| 3 |
PVI
Pura Vida Investments
New York
|
-$690K |
| 4 |
State Street
Boston,
Massachusetts
|
-$452K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$236K |
IRON Hedge Fund Activity: Q2 2022 in Review
50 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Disc Medicine (IRON) for Q2 2022, worth a combined $33.7M — down 15% from $39.6M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of IRON and 13 opened new positions — a net loss of 6 holders — while 16 trimmed existing stakes and 8 added.
The largest buyer was K2 Principal Fund, opening a new position worth an estimated $432K. The largest seller was BlackRock, cutting an estimated $1.6M.
- 50 institutional investors held Disc Medicine (IRON) as of Q2 2022, down from 57 in Q1 2022.
- Funds reported $33.7M of Disc Medicine stock for Q2 2022, down 15% quarter-over-quarter.
- 13 funds opened new Disc Medicine positions in Q2 2022 and 19 closed out, a net change of -6 holders.
- The largest Disc Medicine buyer in Q2 2022 was K2 Principal Fund, an estimated $432K added.
- The largest Disc Medicine seller in Q2 2022 was BlackRock, an estimated $1.6M sold.
Based on aggregated 13F filings for Q2 2022.